vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Strawberry Fields REIT, Inc.（STRW）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Strawberry Fields REIT, Inc.的1.9倍（$75.5M vs $40.1M），Strawberry Fields REIT, Inc.同比增速更快（31.5% vs 27.7%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 20.0%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Strawberry Fields REIT, Inc.是一家专注于医疗类不动产的房地产投资信托，核心资产包含专业护理机构、老年生活社区及医疗办公大楼，业务主要覆盖美国各地市场，为医疗服务商及养老运营主体提供物业支持。
PBYI vs STRW — 直观对比
营收规模更大
PBYI
是对方的1.9倍
$40.1M
营收增速更快
STRW
高出3.8%
27.7%
两年增速更快
PBYI
近两年复合增速
20.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $40.1M |
| 净利润 | — | $2.0M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 52.4% |
| 净利率 | — | 5.0% |
| 营收同比 | 27.7% | 31.5% |
| 净利润同比 | — | 37.6% |
| 每股收益（稀释后） | $0.26 | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISTRW
| Q4 25 | $75.5M | $40.1M | ||
| Q3 25 | $54.5M | $39.7M | ||
| Q2 25 | $52.4M | $37.9M | ||
| Q1 25 | $46.0M | $37.3M | ||
| Q4 24 | $59.1M | $30.5M | ||
| Q3 24 | $80.5M | $29.5M | ||
| Q2 24 | $47.1M | $29.3M | ||
| Q1 24 | $43.8M | $27.8M |
净利润PBYISTRW
| Q4 25 | — | $2.0M | ||
| Q3 25 | $8.8M | $2.0M | ||
| Q2 25 | $5.9M | $2.0M | ||
| Q1 25 | $3.0M | $1.6M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | $20.3M | $944.0K | ||
| Q2 24 | $-4.5M | $938.0K | ||
| Q1 24 | $-4.8M | $746.0K |
毛利率PBYISTRW
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYISTRW
| Q4 25 | 22.7% | 52.4% | ||
| Q3 25 | 17.6% | 56.6% | ||
| Q2 25 | 12.7% | 54.5% | ||
| Q1 25 | 8.7% | 54.1% | ||
| Q4 24 | 22.6% | 51.5% | ||
| Q3 24 | 27.4% | 54.4% | ||
| Q2 24 | -4.6% | 52.3% | ||
| Q1 24 | -5.3% | 51.3% |
净利率PBYISTRW
| Q4 25 | — | 5.0% | ||
| Q3 25 | 16.2% | 5.1% | ||
| Q2 25 | 11.2% | 5.2% | ||
| Q1 25 | 6.5% | 4.2% | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | 25.2% | 3.2% | ||
| Q2 24 | -9.6% | 3.2% | ||
| Q1 24 | -11.0% | 2.7% |
每股收益（稀释后）PBYISTRW
| Q4 25 | $0.26 | $0.15 | ||
| Q3 25 | $0.17 | $0.16 | ||
| Q2 25 | $0.12 | $0.16 | ||
| Q1 25 | $0.06 | $0.13 | ||
| Q4 24 | $0.40 | $0.17 | ||
| Q3 24 | $0.41 | $0.14 | ||
| Q2 24 | $-0.09 | $0.14 | ||
| Q1 24 | $-0.10 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $31.8M |
| 总债务越低越好 | $22.7M | $794.7M |
| 股东权益账面价值 | $130.3M | $12.1M |
| 总资产 | $216.3M | $885.2M |
| 负债/权益比越低杠杆越低 | 0.17× | 65.64× |
8季度趋势，按日历期对齐
现金及短期投资PBYISTRW
| Q4 25 | $97.5M | $31.8M | ||
| Q3 25 | $94.4M | $19.8M | ||
| Q2 25 | $96.0M | $96.3M | ||
| Q1 25 | $93.2M | $42.3M | ||
| Q4 24 | $101.0M | $48.4M | ||
| Q3 24 | $96.7M | $29.3M | ||
| Q2 24 | $96.8M | $16.1M | ||
| Q1 24 | $107.2M | $15.1M |
总债务PBYISTRW
| Q4 25 | $22.7M | $794.7M | ||
| Q3 25 | $34.0M | $779.4M | ||
| Q2 25 | $45.3M | $794.1M | ||
| Q1 25 | $56.7M | $715.5M | ||
| Q4 24 | $68.0M | $673.9M | ||
| Q3 24 | $79.3M | $584.5M | ||
| Q2 24 | $90.7M | $555.0M | ||
| Q1 24 | $102.0M | $560.4M |
股东权益PBYISTRW
| Q4 25 | $130.3M | $12.1M | ||
| Q3 25 | $115.3M | $14.2M | ||
| Q2 25 | $104.7M | $15.5M | ||
| Q1 25 | $97.1M | $19.6M | ||
| Q4 24 | $92.1M | $18.2M | ||
| Q3 24 | $71.1M | $12.6M | ||
| Q2 24 | $48.5M | $7.4M | ||
| Q1 24 | $51.0M | $7.5M |
总资产PBYISTRW
| Q4 25 | $216.3M | $885.2M | ||
| Q3 25 | $202.9M | $880.6M | ||
| Q2 25 | $194.9M | $897.3M | ||
| Q1 25 | $196.2M | $834.8M | ||
| Q4 24 | $213.3M | $787.6M | ||
| Q3 24 | $220.7M | $661.5M | ||
| Q2 24 | $205.0M | $635.9M | ||
| Q1 24 | $214.1M | $634.9M |
负债/权益比PBYISTRW
| Q4 25 | 0.17× | 65.64× | ||
| Q3 25 | 0.30× | 54.70× | ||
| Q2 25 | 0.43× | 51.26× | ||
| Q1 25 | 0.58× | 36.47× | ||
| Q4 24 | 0.74× | 37.09× | ||
| Q3 24 | 1.12× | 46.34× | ||
| Q2 24 | 1.87× | 74.61× | ||
| Q1 24 | 2.00× | 74.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $90.0M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 44.62× |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYISTRW
| Q4 25 | $14.4M | $90.0M | ||
| Q3 25 | $9.7M | $20.7M | ||
| Q2 25 | $14.1M | $29.8M | ||
| Q1 25 | $3.6M | $19.0M | ||
| Q4 24 | $15.6M | $59.3M | ||
| Q3 24 | $11.0M | $11.8M | ||
| Q2 24 | $1.0M | $20.6M | ||
| Q1 24 | $11.2M | $2.1M |
自由现金流PBYISTRW
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYISTRW
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYISTRW
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYISTRW
| Q4 25 | — | 44.62× | ||
| Q3 25 | 1.10× | 10.26× | ||
| Q2 25 | 2.41× | 15.24× | ||
| Q1 25 | 1.21× | 11.97× | ||
| Q4 24 | — | 40.44× | ||
| Q3 24 | 0.54× | 12.53× | ||
| Q2 24 | — | 21.93× | ||
| Q1 24 | — | 2.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
